» Articles » PMID: 33962616

Blocking Circ-CNST Suppresses Malignant Behaviors of Osteosarcoma Cells and Inhibits Glycolysis Through Circ-CNST-miR-578-LDHA/PDK1 CeRNA Networks

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2021 May 8
PMID 33962616
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: CircRNA CNST (circ-CNST) is a newly identified biomarker for prognosis of osteosarcoma (OS). However, its role in OS progression remains to be well documented.

Methods: Expression of circ-CNST, microRNA (miR)-578, lactate dehydrogenase A (LDHA), and pyruvate dehydrogenase kinase 1 (PDK1) was detected by quantitative real-time polymerase chain reaction and Western blotting. The physical interaction was confirmed by dual-luciferase reporter assay. Cell behaviors and glycolysis were measured by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assay, colony formation assay, flow cytometry, transwell assays, xenograft experiment, and commercial kits.

Results: Circ-CNST was upregulated in human OS tissues and cells, accompanied with downregulation of miR-578 and upregulation of LDHA and PDK1. There were negative correlations between miR-578 expression and circ-CNST or LDHA/PDK1 in OS tissues. Moreover, high circ-CNST/LDHA/PDK1 or low miR-578 might predict shorter overall survival, advanced TNM stages, and lymph node metastasis. Physically, miR-578 was targeted by circ-CNST, and miR-578 could target LDHA/PDK1. Functionally, blocking circ-CNST and restoring miR-578 enhanced apoptosis rate and suppressed cell proliferation, colony formation, migration, and invasion in 143B and U2OS cells, accompanied with decreased glucose consumption, lactate production, and adenosine triphosphate (ATP)/adenosine diphosphate (ADP) ratio. Furthermore, in vivo growth of U2OS cells was retarded by silencing circ-CNST. Depletion of miR-578 could counteract the suppressive role of circ-CNST deficiency in 143B and U2OS cells, and restoring LDHA or PDK1 partially reversed the role of miR-578 inhibition as well.

Conclusion: Circ-CNST knockdown could antagonize malignant behaviors and glycolysis of OS cells by regulating miR-578-LDHA/PDK1 axes.

Citing Articles

Exploring the Role of Circular RNA in Bone Biology: A Comprehensive Review.

Valenti M, Zerlotin R, Cominacini M, Bolognin S, Grano M, Dalle Carbonare L Cells. 2024; 13(12.

PMID: 38920630 PMC: 11201515. DOI: 10.3390/cells13120999.


Osteosarcoma in a ceRNET perspective.

Mosca N, Alessio N, Di Paola A, Marrapodi M, Galderisi U, Russo A J Biomed Sci. 2024; 31(1):59.

PMID: 38835012 PMC: 11151680. DOI: 10.1186/s12929-024-01049-y.


Alteration in the Expression of Circular Rnas and its association with the Development and Progression of Osteosarcoma, an Integrative Review with High Sensitivity Research.

Lima F, Fernandes F, Almeida D, Carvalho A, Almeida V, Cavalcante G Asian Pac J Cancer Prev. 2024; 25(4):1195-1203.

PMID: 38679978 PMC: 11162731. DOI: 10.31557/APJCP.2024.25.4.1195.


CircGPC3 promotes hepatocellular carcinoma progression and metastasis by sponging miR-578 and regulating RAB7A/PSME3 expression.

Ju L, Luo Y, Cui X, Zhang H, Chen L, Yao M Sci Rep. 2024; 14(1):7632.

PMID: 38561366 PMC: 10984923. DOI: 10.1038/s41598-024-58004-y.


Identification of circRNA biomarkers in osteosarcoma: An updated systematic review and meta-analysis.

Zhou C, Balmer L, Song M, Mahara G, Wu K, Wang W Noncoding RNA Res. 2024; 9(2):341-349.

PMID: 38505307 PMC: 10945140. DOI: 10.1016/j.ncrna.2024.01.007.


References
1.
Wang C, Jing J, Cheng L . Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma. Invest New Drugs. 2018; 36(6):1116-1132. DOI: 10.1007/s10637-018-0624-7. View

2.
Ji X, Shan L, Shen P, He M . Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression. Cell Death Dis. 2020; 11(1):18. PMC: 6944700. DOI: 10.1038/s41419-019-2204-y. View

3.
Giang A, Raymond T, Brookes P, Bentley K, Schwarz E, OKeefe R . Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the Warburg effect. J Biol Chem. 2013; 288(46):33303-11. PMC: 3829176. DOI: 10.1074/jbc.M113.507129. View

4.
Wan B, Hu H, Wang R, Liu W, Chen D . Therapeutic Potential of Circular RNAs in Osteosarcoma. Front Oncol. 2020; 10:370. PMC: 7174900. DOI: 10.3389/fonc.2020.00370. View

5.
Gao S, Tu D, Li H, Jiang J, Cao X, You J . Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma. Biomed Pharmacother. 2016; 81:388-393. DOI: 10.1016/j.biopha.2016.04.029. View